nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—LYN—blood plasma—Creutzfeldt-Jakob disease	0.0195	0.0279	CbGeAlD
Nilotinib—EPHB2—brainstem—Creutzfeldt-Jakob disease	0.015	0.0215	CbGeAlD
Nilotinib—HCK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0139	0.0463	CbGpPWpGaD
Nilotinib—MAPK14—blood plasma—Creutzfeldt-Jakob disease	0.0134	0.0192	CbGeAlD
Nilotinib—BLK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0126	0.042	CbGpPWpGaD
Nilotinib—FGR—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0126	0.0418	CbGpPWpGaD
Nilotinib—MAPK8—brainstem—Creutzfeldt-Jakob disease	0.012	0.0172	CbGeAlD
Nilotinib—FRK—lymphoid tissue—Creutzfeldt-Jakob disease	0.0108	0.0154	CbGeAlD
Nilotinib—UGT1A1—blood plasma—Creutzfeldt-Jakob disease	0.0105	0.0151	CbGeAlD
Nilotinib—BLK—lymphoid tissue—Creutzfeldt-Jakob disease	0.0104	0.0149	CbGeAlD
Nilotinib—EPHB2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0103	0.0147	CbGeAlD
Nilotinib—EPHB3—brainstem—Creutzfeldt-Jakob disease	0.00991	0.0142	CbGeAlD
Nilotinib—CSF1R—blood plasma—Creutzfeldt-Jakob disease	0.00973	0.0139	CbGeAlD
Nilotinib—KIT—blood plasma—Creutzfeldt-Jakob disease	0.00883	0.0126	CbGeAlD
Nilotinib—EPHA4—brainstem—Creutzfeldt-Jakob disease	0.00827	0.0118	CbGeAlD
Nilotinib—CDC42BPB—spinal cord—Creutzfeldt-Jakob disease	0.00826	0.0118	CbGeAlD
Nilotinib—MAPK8—lymphoid tissue—Creutzfeldt-Jakob disease	0.00824	0.0118	CbGeAlD
Nilotinib—CA1—blood plasma—Creutzfeldt-Jakob disease	0.00808	0.0115	CbGeAlD
Nilotinib—MAPK14—brainstem—Creutzfeldt-Jakob disease	0.00763	0.0109	CbGeAlD
Nilotinib—LYN—lymphoid tissue—Creutzfeldt-Jakob disease	0.0076	0.0109	CbGeAlD
Nilotinib—EPHB2—central nervous system—Creutzfeldt-Jakob disease	0.00758	0.0108	CbGeAlD
Nilotinib—LYN—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00756	0.0252	CbGpPWpGaD
Nilotinib—MAP4K1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00749	0.0107	CbGeAlD
Nilotinib—MAPK8—spinal cord—Creutzfeldt-Jakob disease	0.00747	0.0107	CbGeAlD
Nilotinib—MAPK11—KSRP destabilizes mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00735	0.0245	CbGpPWpGaD
Nilotinib—EPHA8—central nervous system—Creutzfeldt-Jakob disease	0.00727	0.0104	CbGeAlD
Nilotinib—EPHA8—cerebellum—Creutzfeldt-Jakob disease	0.0071	0.0102	CbGeAlD
Nilotinib—MAPK8—Activation of BH3-only proteins—YWHAZ—Creutzfeldt-Jakob disease	0.00678	0.0226	CbGpPWpGaD
Nilotinib—MAPK11—central nervous system—Creutzfeldt-Jakob disease	0.00676	0.00966	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—Creutzfeldt-Jakob disease	0.0067	0.00958	CbGeAlD
Nilotinib—MAPK11—cerebellum—Creutzfeldt-Jakob disease	0.0066	0.00944	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—Creutzfeldt-Jakob disease	0.00655	0.00936	CbGeAlD
Nilotinib—MAPK8—Ceramide signaling pathway—CTSD—Creutzfeldt-Jakob disease	0.00636	0.0212	CbGpPWpGaD
Nilotinib—EPHA3—central nervous system—Creutzfeldt-Jakob disease	0.00635	0.00908	CbGeAlD
Nilotinib—HCK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00624	0.00893	CbGeAlD
Nilotinib—MAPK11—p38 signaling mediated by MAPKAP kinases—YWHAZ—Creutzfeldt-Jakob disease	0.00621	0.0207	CbGpPWpGaD
Nilotinib—LCK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0062	0.0206	CbGpPWpGaD
Nilotinib—EPHB3—spinal cord—Creutzfeldt-Jakob disease	0.00616	0.00881	CbGeAlD
Nilotinib—MAPK8—central nervous system—Creutzfeldt-Jakob disease	0.00606	0.00866	CbGeAlD
Nilotinib—EPHA6—central nervous system—Creutzfeldt-Jakob disease	0.00606	0.00866	CbGeAlD
Nilotinib—EPHB2—brain—Creutzfeldt-Jakob disease	0.00602	0.0086	CbGeAlD
Nilotinib—MAPK8—cerebellum—Creutzfeldt-Jakob disease	0.00592	0.00847	CbGeAlD
Nilotinib—EPHA8—brain—Creutzfeldt-Jakob disease	0.00577	0.00825	CbGeAlD
Nilotinib—HCK—spinal cord—Creutzfeldt-Jakob disease	0.00566	0.00809	CbGeAlD
Nilotinib—MAP2K5—brainstem—Creutzfeldt-Jakob disease	0.00566	0.00809	CbGeAlD
Nilotinib—LYN—central nervous system—Creutzfeldt-Jakob disease	0.00559	0.00799	CbGeAlD
Nilotinib—MAPK11—brain—Creutzfeldt-Jakob disease	0.00536	0.00767	CbGeAlD
Nilotinib—CDC42BPB—brain—Creutzfeldt-Jakob disease	0.00532	0.0076	CbGeAlD
Nilotinib—TIE1—central nervous system—Creutzfeldt-Jakob disease	0.00525	0.00751	CbGeAlD
Nilotinib—MAPK14—KSRP destabilizes mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00525	0.0175	CbGpPWpGaD
Nilotinib—CA2—blood plasma—Creutzfeldt-Jakob disease	0.00524	0.00748	CbGeAlD
Nilotinib—MAPK14—lymphoid tissue—Creutzfeldt-Jakob disease	0.00523	0.00748	CbGeAlD
Nilotinib—FGR—lymphoid tissue—Creutzfeldt-Jakob disease	0.00521	0.00745	CbGeAlD
Nilotinib—TIE1—cerebellum—Creutzfeldt-Jakob disease	0.00514	0.00734	CbGeAlD
Nilotinib—EPHA3—brain—Creutzfeldt-Jakob disease	0.00504	0.00721	CbGeAlD
Nilotinib—KIT—brainstem—Creutzfeldt-Jakob disease	0.00501	0.00717	CbGeAlD
Nilotinib—EPHB3—central nervous system—Creutzfeldt-Jakob disease	0.005	0.00714	CbGeAlD
Nilotinib—CYP2C8—blood plasma—Creutzfeldt-Jakob disease	0.00499	0.00713	CbGeAlD
Nilotinib—BRAF—cerebellum—Creutzfeldt-Jakob disease	0.00492	0.00704	CbGeAlD
Nilotinib—EPHB3—cerebellum—Creutzfeldt-Jakob disease	0.00488	0.00698	CbGeAlD
Nilotinib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DQB1—Creutzfeldt-Jakob disease	0.00488	0.0163	CbGpPWpGaD
Nilotinib—EPHA2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00487	0.00696	CbGeAlD
Nilotinib—MAPK8—Intrinsic Pathway for Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00485	0.0161	CbGpPWpGaD
Nilotinib—EPHA6—brain—Creutzfeldt-Jakob disease	0.00481	0.00688	CbGeAlD
Nilotinib—MAPK8—brain—Creutzfeldt-Jakob disease	0.00481	0.00688	CbGeAlD
Nilotinib—HCK—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00476	0.0158	CbGpPWpGaD
Nilotinib—TEK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00475	0.00679	CbGeAlD
Nilotinib—MAPK14—spinal cord—Creutzfeldt-Jakob disease	0.00474	0.00678	CbGeAlD
Nilotinib—CA14—spinal cord—Creutzfeldt-Jakob disease	0.00461	0.0066	CbGeAlD
Nilotinib—HCK—central nervous system—Creutzfeldt-Jakob disease	0.00459	0.00656	CbGeAlD
Nilotinib—EPHB4—spinal cord—Creutzfeldt-Jakob disease	0.0045	0.00643	CbGeAlD
Nilotinib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DQB1—Creutzfeldt-Jakob disease	0.00449	0.0149	CbGpPWpGaD
Nilotinib—CYP2B6—blood plasma—Creutzfeldt-Jakob disease	0.00447	0.00639	CbGeAlD
Nilotinib—ABL2—cerebellum—Creutzfeldt-Jakob disease	0.00446	0.00638	CbGeAlD
Nilotinib—LYN—brain—Creutzfeldt-Jakob disease	0.00444	0.00635	CbGeAlD
Nilotinib—MAPK14—p38 signaling mediated by MAPKAP kinases—YWHAZ—Creutzfeldt-Jakob disease	0.00443	0.0148	CbGpPWpGaD
Nilotinib—CYP2C9—blood plasma—Creutzfeldt-Jakob disease	0.00443	0.00633	CbGeAlD
Nilotinib—CA7—cerebellum—Creutzfeldt-Jakob disease	0.00439	0.00628	CbGeAlD
Nilotinib—MAP4K1—brain—Creutzfeldt-Jakob disease	0.00437	0.00625	CbGeAlD
Nilotinib—ABL1—brainstem—Creutzfeldt-Jakob disease	0.00436	0.00624	CbGeAlD
Nilotinib—TEK—spinal cord—Creutzfeldt-Jakob disease	0.0043	0.00615	CbGeAlD
Nilotinib—PDGFRA—lymphoid tissue—Creutzfeldt-Jakob disease	0.0043	0.00615	CbGeAlD
Nilotinib—EPHA4—central nervous system—Creutzfeldt-Jakob disease	0.00417	0.00597	CbGeAlD
Nilotinib—TIE1—brain—Creutzfeldt-Jakob disease	0.00417	0.00596	CbGeAlD
Nilotinib—CA3—central nervous system—Creutzfeldt-Jakob disease	0.00412	0.00589	CbGeAlD
Nilotinib—EPHB6—spinal cord—Creutzfeldt-Jakob disease	0.00411	0.00588	CbGeAlD
Nilotinib—EPHA4—cerebellum—Creutzfeldt-Jakob disease	0.00408	0.00583	CbGeAlD
Nilotinib—LCK—PD-1 signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00401	0.0134	CbGpPWpGaD
Nilotinib—BRAF—brain—Creutzfeldt-Jakob disease	0.004	0.00572	CbGeAlD
Nilotinib—EPHB3—brain—Creutzfeldt-Jakob disease	0.00397	0.00567	CbGeAlD
Nilotinib—MAPK8—FoxO family signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00396	0.0132	CbGpPWpGaD
Nilotinib—PDGFRA—spinal cord—Creutzfeldt-Jakob disease	0.0039	0.00557	CbGeAlD
Nilotinib—CA9—cerebellum—Creutzfeldt-Jakob disease	0.00386	0.00551	CbGeAlD
Nilotinib—MAPK14—central nervous system—Creutzfeldt-Jakob disease	0.00385	0.0055	CbGeAlD
Nilotinib—FGR—central nervous system—Creutzfeldt-Jakob disease	0.00383	0.00548	CbGeAlD
Nilotinib—CSF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.00379	0.00541	CbGeAlD
Nilotinib—MAPK14—cerebellum—Creutzfeldt-Jakob disease	0.00376	0.00538	CbGeAlD
Nilotinib—MAPK8—Role of Calcineurin-dependent NFAT signaling in lymphocytes—YWHAZ—Creutzfeldt-Jakob disease	0.00366	0.0122	CbGpPWpGaD
Nilotinib—CA14—cerebellum—Creutzfeldt-Jakob disease	0.00366	0.00523	CbGeAlD
Nilotinib—HCK—brain—Creutzfeldt-Jakob disease	0.00365	0.00521	CbGeAlD
Nilotinib—ABL2—brain—Creutzfeldt-Jakob disease	0.00362	0.00518	CbGeAlD
Nilotinib—CA4—brainstem—Creutzfeldt-Jakob disease	0.00358	0.00512	CbGeAlD
Nilotinib—EPHA2—central nervous system—Creutzfeldt-Jakob disease	0.00358	0.00512	CbGeAlD
Nilotinib—CA7—brain—Creutzfeldt-Jakob disease	0.00357	0.0051	CbGeAlD
Nilotinib—EPHB4—cerebellum—Creutzfeldt-Jakob disease	0.00357	0.0051	CbGeAlD
Nilotinib—EPHA2—Direct p53 effectors—CTSD—Creutzfeldt-Jakob disease	0.00355	0.0118	CbGpPWpGaD
Nilotinib—MAP2K5—spinal cord—Creutzfeldt-Jakob disease	0.00352	0.00503	CbGeAlD
Nilotinib—TEK—central nervous system—Creutzfeldt-Jakob disease	0.00349	0.00499	CbGeAlD
Nilotinib—KIT—lymphoid tissue—Creutzfeldt-Jakob disease	0.00344	0.00491	CbGeAlD
Nilotinib—CSF1R—spinal cord—Creutzfeldt-Jakob disease	0.00343	0.00491	CbGeAlD
Nilotinib—TEK—cerebellum—Creutzfeldt-Jakob disease	0.00341	0.00488	CbGeAlD
Nilotinib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00338	0.00483	CbGeAlD
Nilotinib—PDGFRB—lymphoid tissue—Creutzfeldt-Jakob disease	0.00336	0.0048	CbGeAlD
Nilotinib—MAPK8—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00335	0.0112	CbGpPWpGaD
Nilotinib—EPHB6—central nervous system—Creutzfeldt-Jakob disease	0.00334	0.00477	CbGeAlD
Nilotinib—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.00332	0.00475	CbGeAlD
Nilotinib—EPHA4—brain—Creutzfeldt-Jakob disease	0.00331	0.00474	CbGeAlD
Nilotinib—CA3—brain—Creutzfeldt-Jakob disease	0.00327	0.00468	CbGeAlD
Nilotinib—EPHB6—cerebellum—Creutzfeldt-Jakob disease	0.00326	0.00466	CbGeAlD
Nilotinib—EPHB3—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00318	0.0106	CbGpPWpGaD
Nilotinib—CA3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00317	0.0105	CbGpPWpGaD
Nilotinib—PDGFRA—central nervous system—Creutzfeldt-Jakob disease	0.00316	0.00452	CbGeAlD
Nilotinib—CA1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00314	0.0045	CbGeAlD
Nilotinib—KIT—spinal cord—Creutzfeldt-Jakob disease	0.00312	0.00446	CbGeAlD
Nilotinib—PDGFRA—cerebellum—Creutzfeldt-Jakob disease	0.00309	0.00442	CbGeAlD
Nilotinib—LCK—Generation of second messenger molecules—HLA-DQB1—Creutzfeldt-Jakob disease	0.00308	0.0103	CbGpPWpGaD
Nilotinib—MAPK14—brain—Creutzfeldt-Jakob disease	0.00306	0.00437	CbGeAlD
Nilotinib—PDGFRB—spinal cord—Creutzfeldt-Jakob disease	0.00304	0.00435	CbGeAlD
Nilotinib—FGR—brain—Creutzfeldt-Jakob disease	0.00304	0.00435	CbGeAlD
Nilotinib—ABL1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00299	0.00428	CbGeAlD
Nilotinib—CA14—brain—Creutzfeldt-Jakob disease	0.00297	0.00425	CbGeAlD
Nilotinib—CA2—brainstem—Creutzfeldt-Jakob disease	0.00297	0.00425	CbGeAlD
Nilotinib—LYN—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00297	0.00989	CbGpPWpGaD
Nilotinib—CA12—central nervous system—Creutzfeldt-Jakob disease	0.00292	0.00417	CbGeAlD
Nilotinib—EPHB4—brain—Creutzfeldt-Jakob disease	0.0029	0.00414	CbGeAlD
Nilotinib—MAP2K5—central nervous system—Creutzfeldt-Jakob disease	0.00285	0.00408	CbGeAlD
Nilotinib—CA1—spinal cord—Creutzfeldt-Jakob disease	0.00285	0.00408	CbGeAlD
Nilotinib—EPHA2—brain—Creutzfeldt-Jakob disease	0.00284	0.00406	CbGeAlD
Nilotinib—EPHA3—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00283	0.00943	CbGpPWpGaD
Nilotinib—ABL2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00283	0.00943	CbGpPWpGaD
Nilotinib—MAP2K5—cerebellum—Creutzfeldt-Jakob disease	0.00279	0.00399	CbGeAlD
Nilotinib—CSF1R—central nervous system—Creutzfeldt-Jakob disease	0.00278	0.00398	CbGeAlD
Nilotinib—TEK—brain—Creutzfeldt-Jakob disease	0.00277	0.00396	CbGeAlD
Nilotinib—EPHA8—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00273	0.0091	CbGpPWpGaD
Nilotinib—CSF1R—cerebellum—Creutzfeldt-Jakob disease	0.00272	0.00389	CbGeAlD
Nilotinib—ABL1—spinal cord—Creutzfeldt-Jakob disease	0.00271	0.00388	CbGeAlD
Nilotinib—EPHA4—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.0027	0.009	CbGpPWpGaD
Nilotinib—EPHB4—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.0027	0.009	CbGpPWpGaD
Nilotinib—EPHB6—brain—Creutzfeldt-Jakob disease	0.00265	0.00379	CbGeAlD
Nilotinib—EPHB2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00262	0.00872	CbGpPWpGaD
Nilotinib—LYN—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00259	0.00861	CbGpPWpGaD
Nilotinib—EPHB6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00254	0.00846	CbGpPWpGaD
Nilotinib—KIT—central nervous system—Creutzfeldt-Jakob disease	0.00253	0.00361	CbGeAlD
Nilotinib—LCK—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00253	0.00841	CbGpPWpGaD
Nilotinib—PDGFRA—brain—Creutzfeldt-Jakob disease	0.00251	0.00359	CbGeAlD
Nilotinib—KIT—cerebellum—Creutzfeldt-Jakob disease	0.00247	0.00353	CbGeAlD
Nilotinib—PDGFRB—central nervous system—Creutzfeldt-Jakob disease	0.00247	0.00353	CbGeAlD
Nilotinib—BRAF—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00246	0.00819	CbGpPWpGaD
Nilotinib—PDGFRB—cerebellum—Creutzfeldt-Jakob disease	0.00241	0.00345	CbGeAlD
Nilotinib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00239	0.00342	CbGeAlD
Nilotinib—EPHA6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00239	0.00796	CbGpPWpGaD
Nilotinib—HCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00232	0.00772	CbGpPWpGaD
Nilotinib—CA12—brain—Creutzfeldt-Jakob disease	0.00232	0.00331	CbGeAlD
Nilotinib—CA1—central nervous system—Creutzfeldt-Jakob disease	0.00231	0.00331	CbGeAlD
Nilotinib—EPHB3—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00227	0.00755	CbGpPWpGaD
Nilotinib—MAP2K5—brain—Creutzfeldt-Jakob disease	0.00227	0.00324	CbGeAlD
Nilotinib—CA4—spinal cord—Creutzfeldt-Jakob disease	0.00223	0.00319	CbGeAlD
Nilotinib—CSF1R—brain—Creutzfeldt-Jakob disease	0.00221	0.00316	CbGeAlD
Nilotinib—EPHA2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.0022	0.00734	CbGpPWpGaD
Nilotinib—ABL1—central nervous system—Creutzfeldt-Jakob disease	0.0022	0.00315	CbGeAlD
Nilotinib—ABL1—Pathogenic Escherichia coli infection—YWHAZ—Creutzfeldt-Jakob disease	0.00215	0.00717	CbGpPWpGaD
Nilotinib—ABL1—cerebellum—Creutzfeldt-Jakob disease	0.00215	0.00308	CbGeAlD
Nilotinib—MAPK8—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00215	0.00716	CbGpPWpGaD
Nilotinib—MAPK14—Role of Calcineurin-dependent NFAT signaling in lymphocytes—YWHAZ—Creutzfeldt-Jakob disease	0.00208	0.00693	CbGpPWpGaD
Nilotinib—PDGFRA—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00207	0.00688	CbGpPWpGaD
Nilotinib—HCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00206	0.00687	CbGpPWpGaD
Nilotinib—LYN—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00206	0.00685	CbGpPWpGaD
Nilotinib—MAP2K5—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00204	0.00681	CbGpPWpGaD
Nilotinib—CA14—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00204	0.00679	CbGpPWpGaD
Nilotinib—CA2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00204	0.00291	CbGeAlD
Nilotinib—ABL2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00202	0.00673	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00202	0.00673	CbGpPWpGaD
Nilotinib—MAPK11—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00201	0.00669	CbGpPWpGaD
Nilotinib—KIT—brain—Creutzfeldt-Jakob disease	0.00201	0.00287	CbGeAlD
Nilotinib—CA6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00199	0.00662	CbGpPWpGaD
Nilotinib—PDGFRB—brain—Creutzfeldt-Jakob disease	0.00196	0.0028	CbGeAlD
Nilotinib—EPHA8—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00195	0.00649	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00193	0.00642	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00193	0.00642	CbGpPWpGaD
Nilotinib—LCK—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00189	0.00629	CbGpPWpGaD
Nilotinib—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00189	0.0027	CbGeAlD
Nilotinib—BLK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00187	0.00623	CbGpPWpGaD
Nilotinib—MAPK8—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00187	0.00623	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00187	0.00622	CbGpPWpGaD
Nilotinib—FGR—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00186	0.00621	CbGpPWpGaD
Nilotinib—CA7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00186	0.00618	CbGpPWpGaD
Nilotinib—CA2—spinal cord—Creutzfeldt-Jakob disease	0.00185	0.00264	CbGeAlD
Nilotinib—CA1—brain—Creutzfeldt-Jakob disease	0.00184	0.00262	CbGeAlD
Nilotinib—EPHB6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00181	0.00604	CbGpPWpGaD
Nilotinib—CA4—central nervous system—Creutzfeldt-Jakob disease	0.00181	0.00258	CbGeAlD
Nilotinib—CA4—cerebellum—Creutzfeldt-Jakob disease	0.00177	0.00253	CbGeAlD
Nilotinib—CA3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00175	0.00583	CbGpPWpGaD
Nilotinib—ABL1—brain—Creutzfeldt-Jakob disease	0.00175	0.0025	CbGeAlD
Nilotinib—CYP2B6—lymphoid tissue—Creutzfeldt-Jakob disease	0.00174	0.00249	CbGeAlD
Nilotinib—CA12—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00172	0.00572	CbGpPWpGaD
Nilotinib—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.00171	0.00245	CbGeAlD
Nilotinib—EPHA6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00171	0.00568	CbGpPWpGaD
Nilotinib—BRAF—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.0017	0.00565	CbGpPWpGaD
Nilotinib—LCK—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00169	0.00561	CbGpPWpGaD
Nilotinib—MAPK8—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00157	0.00524	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00157	0.00524	CbGpPWpGaD
Nilotinib—CA2—central nervous system—Creutzfeldt-Jakob disease	0.0015	0.00214	CbGeAlD
Nilotinib—BRAF—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00148	0.00491	CbGpPWpGaD
Nilotinib—CA2—cerebellum—Creutzfeldt-Jakob disease	0.00147	0.00209	CbGeAlD
Nilotinib—CA4—brain—Creutzfeldt-Jakob disease	0.00144	0.00205	CbGeAlD
Nilotinib—MAPK14—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00143	0.00478	CbGpPWpGaD
Nilotinib—CA4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00137	0.00456	CbGpPWpGaD
Nilotinib—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.00136	0.00194	CbGeAlD
Nilotinib—CA2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00131	0.00438	CbGpPWpGaD
Nilotinib—ABL1—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.00131	0.00437	CbGpPWpGaD
Nilotinib—CYP2B6—central nervous system—Creutzfeldt-Jakob disease	0.00128	0.00183	CbGeAlD
Nilotinib—LYN—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00126	0.0042	CbGpPWpGaD
Nilotinib—CA1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00126	0.00419	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00122	0.00406	CbGpPWpGaD
Nilotinib—CA2—brain—Creutzfeldt-Jakob disease	0.00119	0.0017	CbGeAlD
Nilotinib—PDGFRB—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00115	0.00382	CbGpPWpGaD
Nilotinib—CYP2C8—brain—Creutzfeldt-Jakob disease	0.00113	0.00162	CbGeAlD
Nilotinib—CA14—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00113	0.00375	CbGpPWpGaD
Nilotinib—LYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00112	0.00374	CbGpPWpGaD
Nilotinib—ABL1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00112	0.00372	CbGpPWpGaD
Nilotinib—CA9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00111	0.00369	CbGpPWpGaD
Nilotinib—ABCG2—brain—Creutzfeldt-Jakob disease	0.0011	0.00158	CbGeAlD
Nilotinib—CA6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.0011	0.00366	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00108	0.0036	CbGpPWpGaD
Nilotinib—LCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00103	0.00344	CbGpPWpGaD
Nilotinib—CA7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00103	0.00342	CbGpPWpGaD
Nilotinib—CYP2B6—brain—Creutzfeldt-Jakob disease	0.00102	0.00145	CbGeAlD
Nilotinib—LYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00101	0.00335	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.001	0.00333	CbGpPWpGaD
Nilotinib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.000967	0.00138	CbGeAlD
Nilotinib—MAPK11—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000953	0.00317	CbGpPWpGaD
Nilotinib—MAPK11—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.000952	0.00317	CbGpPWpGaD
Nilotinib—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.000952	0.00136	CbGeAlD
Nilotinib—CA12—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00095	0.00316	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000945	0.00315	CbGpPWpGaD
Nilotinib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.000931	0.00133	CbGeAlD
Nilotinib—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.00093	0.00133	CbGeAlD
Nilotinib—LCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00092	0.00306	CbGpPWpGaD
Nilotinib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.000844	0.00121	CbGeAlD
Nilotinib—BLK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000835	0.00278	CbGpPWpGaD
Nilotinib—MAPK11—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.000815	0.00271	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000783	0.00261	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00078	0.0026	CbGpPWpGaD
Nilotinib—CA4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000758	0.00252	CbGpPWpGaD
Nilotinib—CYP2D6—brain—Creutzfeldt-Jakob disease	0.000756	0.00108	CbGeAlD
Nilotinib—CA2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000727	0.00242	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000717	0.00239	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000714	0.00238	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000711	0.00237	CbGpPWpGaD
Nilotinib—CA1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000697	0.00232	CbGpPWpGaD
Nilotinib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.000685	0.000979	CbGeAlD
Nilotinib—MAPK14—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00068	0.00226	CbGpPWpGaD
Nilotinib—MAPK14—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.000679	0.00226	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000674	0.00224	CbGpPWpGaD
Nilotinib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.000669	0.000956	CbGeAlD
Nilotinib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000663	0.00221	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00066	0.0022	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000635	0.00211	CbGpPWpGaD
Nilotinib—CA9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000612	0.00204	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000609	0.00203	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.0006	0.002	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000595	0.00198	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000589	0.00196	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000583	0.00194	CbGpPWpGaD
Nilotinib—MAPK14—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.000581	0.00194	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000568	0.00189	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00056	0.00186	CbGpPWpGaD
Nilotinib—HCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000559	0.00186	CbGpPWpGaD
Nilotinib—ABCB1—brain—Creutzfeldt-Jakob disease	0.000543	0.000777	CbGeAlD
Nilotinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000543	0.00181	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000528	0.00176	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000512	0.0017	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000507	0.00169	CbGpPWpGaD
Nilotinib—BLK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000507	0.00169	CbGpPWpGaD
Nilotinib—FGR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000505	0.00168	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000501	0.00167	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000482	0.00161	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000431	0.00144	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000428	0.00142	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000411	0.00137	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00041	0.00137	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000405	0.00135	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000404	0.00134	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000398	0.00133	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00038	0.00126	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000367	0.00122	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000365	0.00121	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000365	0.00121	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000365	0.00121	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000364	0.00121	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000361	0.0012	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000361	0.0012	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00036	0.0012	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000359	0.0012	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000357	0.00119	CbGpPWpGaD
Nilotinib—HCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000354	0.00118	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000351	0.00117	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000348	0.00116	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000347	0.00116	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000345	0.00115	CbGpPWpGaD
Nilotinib—HCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000327	0.00109	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000324	0.00108	CbGpPWpGaD
Nilotinib—BLK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000321	0.00107	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000321	0.00107	CbGpPWpGaD
Nilotinib—FGR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000319	0.00106	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000317	0.00106	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00031	0.00103	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00031	0.00103	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000304	0.00101	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000303	0.00101	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000302	0.00101	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000301	0.001	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000293	0.000974	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000288	0.000959	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000288	0.000957	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000285	0.00095	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000283	0.000941	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00026	0.000865	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000259	0.000863	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000255	0.00085	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000254	0.000845	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000249	0.000829	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000245	0.000817	CbGpPWpGaD
Nilotinib—BRAF—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000234	0.000777	CbGpPWpGaD
Nilotinib—KIT—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00023	0.000766	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000227	0.000755	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000221	0.000736	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000218	0.000726	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000217	0.000721	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000216	0.000717	CbGpPWpGaD
Nilotinib—KIT—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000213	0.000708	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000207	0.00069	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000205	0.000683	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000201	0.00067	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000197	0.000656	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000196	0.000654	CbGpPWpGaD
Nilotinib—LYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000192	0.00064	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000192	0.000639	CbGpPWpGaD
Nilotinib—ABL1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000191	0.000637	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000187	0.000621	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000182	0.000607	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000181	0.000603	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000181	0.000603	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000177	0.000591	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000167	0.000557	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000165	0.00055	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000164	0.000544	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000158	0.000525	CbGpPWpGaD
Nilotinib—LCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000158	0.000525	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000156	0.00052	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000149	0.000496	CbGpPWpGaD
Nilotinib—LCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000145	0.000484	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000141	0.000469	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000127	0.000423	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000124	0.000414	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000118	0.000392	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000103	0.000343	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000102	0.000339	CbGpPWpGaD
